1 year return (CAGR)
46.69%
Incyte Corporation Exchange (NASDAQ, USD)
INCY
126.93
+2.28 (+1.83%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
26.60%
5 year return (CAGR)
11.93%
10 year return (CAGR)
4.57%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
25.73B
Price/Sales
4.42
Ent value
23.27B
Price/Book
4.06
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
15.96
PEG
-
Forward P/E
14.20
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 124.72 |
| Daily high | 127.69 |
| Daily low | 124.02 |
| Daily Volume | 1.64M |
| All-time high | 152.66 |
| 1y analyst estimate | 127.13 |
| Beta | 0.77 |
| EPS (TTM) | 7.74 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Feb 2026 |
Downside potential
Loading...
Downside potential data
| INCY | S&P500 | |
| Current price drop from All-time high | -16.85% | -0.58% |
| Highest price drop | -98.54% | -56.47% |
| Date of highest drop | 9 Mar 2009 | 9 Mar 2009 |
| Avg drop from high | -59.58% | -10.68% |
| Avg time to new high | 70 days | 12 days |
| Max time to new high | 4286 days | 1805 days |
News
